China mushroom lab starts selling viral strain

The project began with a mushroom growing on a decaying apple, but the bigger investment case is what followed: a lab that has since received samples from across China, expanded its collection to more than 40 kinds of fruit, food and household items, and bred multiple new strains by cross-pollinating and screening hundreds of times. One strain, Xiang Fei, is said to have a crisp texture, heat tolerance and a faint apple aroma — exactly the kind of differentiated feature set that can support premium pricing if production can be standardized.

For investors, the key takeaway is that the bottleneck is no longer curiosity; it is commercialization. Xu is already selling a small amount on Xiaohongshu at 19.9 yuan, or about $2.80, for 100 grams, and the team has discussed getting the strain onto shelves at Freshippo, Alibaba’s supermarket chain. That is a meaningful signal, because the next phase will test whether a social-media-born food brand can move from niche demand to repeatable retail distribution, regulatory clearance and reliable mass production.

The economics are straightforward. China’s food and agriculture market rewards any product that can combine novelty with better storage, stronger branding and defensible supply. The lab says Xiang Fei may store better than some common varieties, while also offering better taste. If those claims hold up under larger-scale testing, the upside extends beyond mushrooms themselves to the broader business of directed breeding, specialty produce and urban food-tech ventures that can turn viral attention into saleable IP.

But the hard part is still ahead. The team lacks the capital and labor to produce at scale, must complete food-safety checks for heavy metals and pesticide residue, and still needs to solve manufacturing, logistics and quality control. That means this is not yet a mass-market mushroom story; it is an early-stage proof of concept. Even so, early-stage is where the asymmetric opportunity sits. In a market increasingly hungry for premium local brands and functional foods, the companies that can industrialize this kind of discovery platform may end up owning the value chain.

The broader implication is that China’s consumer and agricultural innovation ecosystem may be entering a more experimental phase, where a viral moment can evolve into a commercial product line. If that happens, the real winners may not be the one-off mushroom sellers, but the retailers, agribusiness operators and food-tech platforms that can scale the next unusual strain faster than everyone else.